The IDEXX SDMA test:

An influential new kidney diagnostic


SDMA (symmetric dimethylarginine) has been shown in controlled studies in dogs and cats to be a more sensitive biomarker of renal function than creatinine and has recently been added to the International Renal Interest Society (IRIS) Chronic Kidney Disease (CKD) Staging Guidelines.

Veterinarians in North America have submitted more than one million IDEXX SDMA tests since it was introduced in July 2015. The IDEXX SDMA test data suggests that kidney disease is more prevalent than previously estimated with creatinine assessment alone.

By using this simple blood test, veterinarians could be detecting kidney disease in over 2 times the number of cats and dogs than with traditional methods. The IDEXX SDMA test is earning a place as a powerful and influential new kidney test.

Learn more about SDMA, the impact of the IDEXX SDMA test on veterinarians’ diagnosis and treatment of chronic kidney disease, and find answers to the most frequently asked questions below.

An Introduction to IDEXX SDMA

Impact of IDEXX SDMA on diagnosis and management of kidney disease

IDEXX SDMA Frequently Asked Questions

IDEXX SDMA test availability grows worldwide

IDEXX SDMA introduced in Europe

The IDEXX SDMA test is now part of the routine chemistry panels for customers in Germany, Switzerland, and Finland, starting December 1, 2015. Laboratories in the Netherlands, the Nordic countries, and the UK also celebrated successful product launches of the IDEXX SDMA test.

Australian National Association of Testing Authorities (NATA) accredit IDEXX SDMA

Veterinarians across Australia have access to the IDEXX SDMA test—ahead of schedule—after a successful study by a panel of internal medicine specialists demonstrated clear benefits of the test. NATA accredited the IDEXX SDMA test across the four Australian laboratories.

Japan releases Urine P:C Ratio (UPC) slide for Catalyst Dx Chemistry Analyzer

We now offer the Urine P:C Ratio (UPC) slide for the Catalyst Dx Chemistry Analyzer in Japan and are preparing for the launch of the IDEXX SDMA test for a comprehensive diagnostic and management solution for chronic kidney disease (CKD).